Vectorized antibodies hold promise to overcome many of these limitations and provide a great opportunity for DNA and RNA technology companies to enter larger markets compared with the rare disease ...

The tool uses checksum matching to run on select applications, which raises critical questions about the validity of ...

Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...

Please provide your email address to receive an email when new articles are posted on . VTx-002 targets proteins that play a significant role in neurodegenerative disease. Enrollment in and ...

Streaming data is not new. Kafka has existed as an open source tool for a decade. Vectorized was founded on the premise that the existing tools were too complex and not designed for today’s streaming ...

SAN FRANCISCO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vectorized, Inc., the Intelligent Data API company, today announced the general availability of Redpanda, the Intelligent Data API Platform. Vectorized ...

A year after AbbVie and Voyager Therapeutics teamed up on Alzheimer’s disease, they are expanding their partnership to include Parkinson’s disease and other diseases in which misfolded alpha-synuclein ...

PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology ...

Not all drug targets are created equal. For those that result in a tissue-specific gain-of-function, the strategy can be not-so-straightforward. That’s exactly what’s going on in some forms of ...

Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » Vectory Therapeutics closes series A financing to advance vectorized antibody ...